The dual mechanism of the antifungal effect of new lysosomotropic agents on the Saccharomyces cerevisiae RXII strain.
Quinacrine was used to visualize the intracellular pH changes in the yeast strain Saccharomyces cerevisiae RXII occurring after exposure to four recently-synthesized lysosomotropic drugs: DM-11, PY-11, PYG-12s and DMAL-12s. The cells took up quinacrine, mostly accumulating it in their vacuoles. DM-11 and PY-11 gave rise to diffuse quinacrine fluorescence throughout the cells, with the vacuoles staining to a somewhat greater extent than the cytosol. This quinacrine-detected overall acidification of the cell interior is very probably caused by blocking of plasma membrane H(+)-ATPase. PYG-12s gave rise to a strong vacuolar accumulation of the dye. Like the vacuolar ATPase inhibitor bafilomycin A(1), DMAL-12s strongly lowered the intensity of quinacrine fluorescence. Owing to its low pK(a), it can penetrate rapidly into the cells and may inhibit vacuolar H(+)-ATPase and prevent quinacrine-detectable vacuolar acidification without causing strong cell acidification. Since these drugs were found to penetrate into the cells, their lack of effect may reflect a higher resistance of both plasma membrane H(+)-ATPase and vacuolar ATPase to the drugs. Our data indicate that the lysosomotropic drugs under study have a dual action. On entering the cell, they cause intracellular acidification, very probably by inhibiting plasma membrane H(+)-ATPase and curtailing active proton pumping from the cells. Furthermore, they interfere with the function of V-type ATPase, causing vacuolar alkalinization and eventually cell death.
Krasowska
Anna
A
Institute of Microbiology, Wrocław University, Przybyszewskiego 63-77, Poland. aniak@microb.uni.wroc.pl
Chmielewska
Lucyna
L
Łuczyński
Jacek
J
Witek
Stanisław
S
Sigler
Karel
K
D000935:Antifungal Agents / Q000737:chemistry / Q000494:pharmacology*; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D005456:Fluorescent Dyes / Q000493:pharmacokinetics; D006863:Hydrogen-Ion Concentration; D007424:Intracellular Fluid / Q000187:drug effects / Q000378:metabolism; D008247:Lysosomes / Q000187:drug effects*; D008856:Microscopy, Fluorescence; D006180:Proton-Translocating ATPases / Q000378:metabolism; D011796:Quinacrine / Q000493:pharmacokinetics; D012441:Saccharomyces cerevisiae / Q000187:drug effects* / Q000378:metabolism; D025262:Vacuolar Proton-Translocating ATPases / Q000378:metabolism; D014617:Vacuoles / Q000187:drug effects / Q000378:metabolism
D000935:Antifungal Agents; D005456:Fluorescent Dyes; D025262:Vacuolar Proton-Translocating ATPases; D006180:Proton-Translocating ATPases; D011796:Quinacrine